These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11157380)

  • 1. Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy.
    Gang X; Ueki K; Kon S; Maeda M; Naruse T; Nojima Y
    Am J Kidney Dis; 2001 Feb; 37(2):374-9. PubMed ID: 11157380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analyses of osteopontin mRNA expression in human proximal tubules isolated from renal biopsy tissue sections of minimal change nephrotic syndrome and IgA glomerulonephropathy patients.
    Kaimori JY; Takenaka M; Nagasawa Y; Nakajima H; Izumi M; Akagi Y; Imai E; Hori M
    Am J Kidney Dis; 2002 May; 39(5):948-57. PubMed ID: 11979338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
    Taira K; Hewitson TD; Kincaid-Smith P
    Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
    Tencer J; Torffvit O; Björnsson S; Thysell H; Grubb A; Rippe B
    Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases.
    Mitsuhashi H; Tsukada Y; Ono K; Yano S; Naruse T
    Clin Nephrol; 1993 May; 39(5):231-8. PubMed ID: 8513598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy.
    Kobayashi S; Amano H; Terawaki H; Ogura M; Kawaguchi Y; Yokoo T
    BMC Nephrol; 2019 Aug; 20(1):306. PubMed ID: 31387546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis.
    Kitagori K; Yoshifuji H; Oku T; Sasaki C; Miyata H; Mori KP; Nakajima T; Ohmura K; Kawabata D; Yukawa N; Imura Y; Murakami K; Nakashima R; Usui T; Fujii T; Sakai K; Yanagita M; Hirayama Y; Mimori T
    PLoS One; 2016; 11(12):e0167141. PubMed ID: 27992535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
    Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy.
    Fujita T; Nakamura N; Kumasaka R; Shimada M; Murakami R; Osawa H; Yamabe H; Okumura K
    In Vivo; 2006; 20(6B):891-3. PubMed ID: 17203785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin Gene Polymorphism and Urinary OPN Excretion in Patients with Immunoglobulin A Nephropathy.
    Kaleta B; Krata N; Zagożdżon R; Mucha K
    Cells; 2019 May; 8(6):. PubMed ID: 31159229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary levels of macrophage migration inhibitory factor in patients with IgA nephropathy.
    Matsumoto K; Kanmatsuse K
    Nephron; 2002 Oct; 92(2):309-15. PubMed ID: 12218308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.
    Lopez CA; Hoyer JR; Wilson PD; Waterhouse P; Denhardt DT
    Lab Invest; 1993 Sep; 69(3):355-63. PubMed ID: 8377476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy.
    Sakamoto-Ihara T; Suzuki Y; Kurusu A; Yamashita M; Horikoshi S; Tomino Y
    Inflamm Res; 2007 Oct; 56(10):421-7. PubMed ID: 18026699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
    Gao YA; Agnihotri R; Vary CP; Liaw L
    Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat.
    Yu XQ; Nikolic-Paterson DJ; Mu W; Giachelli CM; Atkins RC; Johnson RJ; Lan HY
    Proc Assoc Am Physicians; 1998; 110(1):50-64. PubMed ID: 9460083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
    Singhal H; Bautista DS; Tonkin KS; O'Malley FP; Tuck AB; Chambers AF; Harris JF
    Clin Cancer Res; 1997 Apr; 3(4):605-11. PubMed ID: 9815727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubular osteopontin expression in human glomerulonephritis and renal vasculitis.
    Okada H; Moriwaki K; Konishi K; Kobayashi T; Sugahara S; Nakamoto H; Saruta T; Suzuki H
    Am J Kidney Dis; 2000 Sep; 36(3):498-506. PubMed ID: 10977781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.